LEADER 00779nam0-22002891i-450- 001 990003150600403321 035 $a000315060 035 $aFED01000315060 035 $a(Aleph)000315060FED01 035 $a000315060 100 $a20000920d1963----km-y0itay50------ba 101 0 $aita 102 $aIT 200 1 $aOutsiders$eStudies in the Sociology of Deviance$fHoward S. Becker.. 210 $aNew York$cFree Press of Glencoe$d1963. 215 $aX, 176 p.$d18 cm 610 0 $aDevianza sociale 676 $a20100 702 1$aBecker,$bHoward Saul$f<1928- > 801 0$aIT$bUNINA$gRICA$2UNIMARC 901 $aBK 912 $a990003150600403321 952 $a20100 BEC/63$b031307$fSES 959 $aSES 996 $aOutsiders$9456337 997 $aUNINA DB $aING01 LEADER 01371nam a22003131i 4500 001 991001233839707536 005 20021202163106.0 008 021202s1991 it |||||||||||||||||ita 020 $a8822238524 035 $ab12118643-39ule_inst 035 $aARCHE-020844$9ExL 040 $aDip.to Filologia Ling. e Lett.$bita$cA.t.i. Arché s.c.r.l. Pandora Sicilia s.r.l. 082 04$a271.102 100 0 $aGiovanni :$cdalle Celle$0172555 245 10$aLettere /$cGiovanni dalle Celle, Luigi Marsili ; a cura di Francesco Giambonini 260 $aFirenze :$bL.S. Olschki,$c1991 300 $a2 v. (602 p. compless.) ;$c24 cm 440 0$aStudi e testi / Istituto nazionale di studi sul Rinascimento ;$v22 650 4$aDalle Celle, Giovanni$xLettere e carteggi 650 4$aMarsili, Luigi$xLettere e carteggi 700 1 $aMarsili, Luigi$eauthor$4http://id.loc.gov/vocabulary/relators/aut$0172557 700 1 $aGiambonini, Francesco 907 $a.b12118643$b02-04-14$c01-04-03 912 $a991001233839707536 945 $aLE008 TS M I 3 V.02$cV. 2$g1$i2008000400972$lle008$o-$pE0.00$q-$rl$s- $t0$u0$v0$w0$x0$y.i1242819x$z01-04-03 945 $aLE008 TS M I 3 V.01$cV. 1$g1$i2008000400965$lle008$o-$pE0.00$q-$rl$s- $t0$u0$v0$w0$x0$y.i12428206$z01-04-03 996 $aLettere$91457875 997 $aUNISALENTO 998 $ale008$b01-04-03$cm$da $e-$fita$git $h0$i2 LEADER 03332nam 2200649Ia 450 001 9910783717903321 005 20230828210631.0 010 $a1-281-74404-2 010 $a9786611744045 010 $a1-4237-9009-X 010 $a92-4-068058-6 024 3 $z9789241546942 035 $a(CKB)1000000000247153 035 $a(EBL)284772 035 $a(OCoLC)476035299 035 $a(SSID)ssj0000166545 035 $a(PQKBManifestationID)11924566 035 $a(PQKBTitleCode)TC0000166545 035 $a(PQKBWorkID)10145944 035 $a(PQKB)11452961 035 $a(MiAaPQ)EBC284772 035 $a(Au-PeEL)EBL284772 035 $a(CaPaEBR)ebr10137828 035 $a(CaONFJC)MIL174404 035 $a(EXLCZ)991000000000247153 100 $a20060525d2006 uy 0 101 0 $aeng 135 $aur|n|---||||| 181 $ctxt 182 $cc 183 $acr 200 00$aGuidelines for the treatment of malaria$b[electronic resource] /$fWorld Health Organization 210 $aGeneva $cWorld Health Organization$dc2006 215 $a1 online resource (266 p.) 300 $aDescription based upon print version of record. 311 $a92-4-154694-8 320 $aIncludes bibliographical references and index. 327 $aPreliminaries; Contents; 1 Introduction; 2 The clinical disease; 3 Treatment objectives; 4 Diagnosis of malaria; 5 Resistance to antimalarial medicines; 6 Antimalarial treatment policy; 7 Treatment of uncomplicated P falciparum malaria; 8 Treatment of severe falciparum malaria; 9 Treatment of malaria caused by P vivax P ovale or P malariae; 10 Mixed malaria infections; 11 Complex emergencies and epidemics; Annex 1. The guidelines development process; Annex 2. Adaptation of WHO malaria treatment guidelines for use in countries; Annex 3. Pharmacology of antimalarial drugs 327 $aAnnex 4. Antimalarials and malaria transmissionAnnex 5. Malaria diagnosis; Annex 6. Resistance to antimalarials; Annex 7. Uncomplicated P. falciparum malaria; Annex 8. Malaria treatment and HIV/AIDS; Annex 9. Treatment of severe P. falciparum malaria; Annex 10. Treatment of P. vivax, P. ovale and P. malariae infections; Index 330 $aMalaria is an important cause of death and illness in children and adults in tropical countries. Mortality, currently estimated at over a million people per year, has risen in recent years, probably due to increasing resistance to antimalarial medicines. Malaria control requires an integrated approach comprising prevention including vector control and treatment with effective antimalarials.The affordable and widely available antimalarial chloroquine which was in the past a mainstay of malaria control is now ineffective in most falciparum malaria endemic areas, and resistance to sulfadoxine-pyr 606 $aMalaria$xChemotherapy 606 $aAntimalarials 606 $aMalaria$xDiagnosis 615 0$aMalaria$xChemotherapy. 615 0$aAntimalarials. 615 0$aMalaria$xDiagnosis. 676 $a616.9/36206 676 $a616.9362 686 $a44.75$2bcl 712 02$aWorld Health Organization. 801 0$bMiAaPQ 801 1$bMiAaPQ 801 2$bMiAaPQ 906 $aBOOK 912 $a9910783717903321 996 $aGuidelines for the treatment of malaria$93768024 997 $aUNINA